Sodium Citrate 4% 3 mL, Anticoagulation Solution Injection (Concentration = 40/mg/mL) 3mL fill Sy...

FDA Recall #D-0422-2024 — Class II — November 9, 2023

Recall #D-0422-2024 Date: November 9, 2023 Classification: Class II Status: Terminated

Product Description

Sodium Citrate 4% 3 mL, Anticoagulation Solution Injection (Concentration = 40/mg/mL) 3mL fill Syringe, Repackaged by SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0900-25, Bar Code 70004090025

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

SCA Pharmaceuticals, LLC — Windsor, CT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

9,624 syringes

Distribution

Nationwide in the USA

Code Information

Lot #: 1223048444 Exp 11/20/23; 1223049011 Exp 12/12/23; 1223049673 Exp 01/09/24; 1223049771 Exp 01/12/24

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated